JC
JPMorgan Chase & Co disclosed a 5.3% stake in RGNX
JPMorgan Chase & Co reported owning 5.3% of REGENXBIO Inc. (RGNX) (3,560,915 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
JPMorgan Chase & Co reported owning 5.3% of REGENXBIO Inc. (RGNX) (3,560,915 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.